期刊文献+

4,6-双苯基-2-氨基-3-氰基吡啶类化合物的合成及其抗肿瘤活性研究 被引量:2

Synthesis and antitumor activity of 4,6-diphenyl-2-amino-3-cyanopyridine derivatives
原文传递
导出
摘要 目的设计合成一系列46,-双苯基-2-氨基-3-氰基吡啶类化合物,并对其体外抗肿瘤活性进行初步评价。方法以取代苯甲醛、取代苯乙酮、丙二腈和醋酸铵为原料,经一步反应制得目标化合物。采用MTT法,以MX-58151为阳性对照药,以A549、HT-29和SMMC-7721为测试细胞株对目标化合物进行体外抗肿瘤活性评价。结果与结论合成了13个未见报道的46,-双苯基-2-氨基-3-氰基吡啶类化合物,其结构经1H-NMR、MS和IR谱确证。体外活性测试结果显示,多数化合物能够在较低的浓度下抑制肿瘤细胞增殖。其中,2-氨基-6-(4-氟苯基)-4-(23,,4-三甲氧基苯基)-3-氰基吡啶具有显著的抗肿瘤细胞增殖活性I,C50值达纳摩尔级水平,明显优于阳性对照药MX-58151。 A small molecule with a 4H-chromene core,MX-58151,with potent anticancer activity in vitro was identified by using the cell-and caspase-based high throughput screening assay.On the basis of scaffold hopping,together with an understanding of the SARs relating to 4-aryl-4H-chromenes,thirteen 4,6-diphenyl-2-amino-3-cyanopyridine derivatives were synthesized in attempt to develop active antitumor agents.The target compounds were synthesized via a one-pot reaction and their chemical structures were confirmed by IR,MS,1H-NMR.The cytotoxic activity of these target compounds was evaluated in vitro by MTT assay against A549,HT-29 and SMMC-7721,with MX-58151 as the positive control.Most of the evaluated compounds exhibited moderate cytotoxic activity against three cancer cell lines.Among them,2-amino-6-(4-fluorophenyl)-4-(2,3,4-trimethoxyphenyl)nicotinonitrile(1) exhibited potent anticancer activity against the A549,HF-29,and SMMC-7721 cell lines with IC50 values of 10,0.33 and 0.25 nmol·L-1,respectively.The preliminary SARs analysis showed that introduction of small lipid-soluble groups on phenyl at C-4 position of pyridine and fluoro atom on phenyl at C-6 position of pyridine was benefit for their activity.
出处 《中国药物化学杂志》 CAS CSCD 2011年第5期352-357,共6页 Chinese Journal of Medicinal Chemistry
基金 “重大新药创制”科技重大专项(2009ZX09301-012)
关键词 4 6-双苯基-2-氨基-3-氰基吡啶 合成 抗肿瘤活性 4 6-diphenyl-2-amino-3-cyanopyridine synthesis antitumor activity
  • 相关文献

参考文献10

  • 1HERON M. Leading causes for 2006 [J ]. Natl Vital Stat Rep,2010,58(14) :1 - 100.
  • 2HERON M. Leading causes for 2004[J].Natl Vital Stat Rep,2007,56(5) :1 -96.
  • 3KEMNITZER W, DREWE J, JIANG S C, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group [ J ]. J Med Chem, 2004,47 (25) :6299 - 6310.
  • 4KEMNITZER W, KASIBHATLA S, JIANG S C, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-position [J]. B ioorg Med Chem Lett,2005,15 (21) :4745 -4751.
  • 5KEMNITZER W, DREWE J, JIANG S C, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-position[ J ]. J Med Chem,2007,50 ( 12 ) : 2858 - 2864.
  • 6KEMNITZER W, DREWE J, JIANG S C, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions [J].J Med Chem, 2008,51 ( 3 ) : 417 -423.
  • 7KEMNITZER W, JIANG S C, WANG Y, et al. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Part 5. Modifications of the 2- and 3-positions [J].Bioorg IVied Chem Lett, 2008,18 ( 2 ) : 603 - 607.
  • 8KASIBHATLA S, GOURDEAU H, MEEROVITCH K, et al. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascu- lar targeting activity [J ]. Mol Cancer Ther, 2004,3 ( 11 ) : 1365 - 1374.
  • 9GOURDEAU H, LEBLOND L, HAMELIN B, et al. Antivascular and antitumor evaluation of 2-amino-4-(3- bromo-4,5-dimethoxy-phenyl ) -3 -cyano-4H-chromenes, a novel series of anticancer agents [ J ]. Mol Cancer Ther,2004,3 ( 11 ) :1375 - 1384.
  • 10CAI S X, DREWE J, KEMNITZER W, et al. Discovery of 4-aryl-4H-chromenes as potent apoptosis inducers using a cell- and caspase-based anti-cancer screening apoptosis program (ASAP) : SAR studies and the identification of novel vascular disrupting agents [ J ]. Anticancer Agents Med Chem, 2009,9 (4) :437 -456.

同被引文献17

  • 1吕金玲,赵临襄.苹果酸舒尼替尼(sunitinib malate)[J].中国药物化学杂志,2007,17(3):194-194. 被引量:5
  • 2Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med,1971,285(21):l182-1186.
  • 3Bergers G, Benjamin IrE. Tumorigenesis and the angiogenic switch[J]. Nat Rev Cancer,2003,3(6):401-410.
  • 4Brem S,Brem H,Folkman J,et al. Prolonged tumor dormancy by prevention of neovascularization in the vitreous[J]. Cancer Res, 1976,36(8) : 2807-2812.
  • 5FongTA,Shawver LK,Sun L,etal. Su5416 is a potent and selective inhibitor o{ the vascular tyrosine kinase catalysis, tumor vaseularization, and growth endothelial growth factor re- ceptor (FIk-1/KDR) that inhibits of multiple tumor types~J3. Cancer Res, 1999,59 ( 1 ) ~ 99-106.
  • 6Belleri M,Rihatti D, Nicoli S,et al. Antiangiogenic and vascu lar-targeting activity of the microtubule-destabilizing trans-res- veratrol derivative 3,5,4'-trimethoxystilbeneEJ3. Mol Pharma- co1,2005,67(5) :145]-1459.
  • 7Gieni RS, Li Y, Hayglass KT. Comparison of E:~ HI thymidine incorporation with MTT- and MTS-based bioassays for hu- manand murine IL-2 and IL-4 analysis, tetrazolium assays pro- vide markedly enhanced sensitivity I-J1. J Immunol Methods, 1995,187(1)~85-93.
  • 8Hamel E. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin[J]. Cell Biochem Biophys, 2003,38 (1) : 1-22.
  • 9陈春辉,展恩胜,李勇,申文杰.α,β-不饱和酸多相不对称氢化反应中的钯粒径和载体酸性效应(英文)[J].化学学报,2013,71(11):1505-1510. 被引量:5
  • 10任桐,林锦彬,刁勇.阿比特龙在治疗前列腺癌方面的新进展[J].中国生化药物杂志,2016,36(7):205-208. 被引量:7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部